Association Between Mutation Size and Cardiac Involvement in Myotonic Dystrophy Type 1 - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Circulation: Cardiovascular Genetics Année : 2017

Association Between Mutation Size and Cardiac Involvement in Myotonic Dystrophy Type 1

Caroline Chong-Nguyen
  • Fonction : Auteur
Karim Wahbi
  • Fonction : Auteur
Vincent Algalarrondo
  • Fonction : Auteur
Henri Marc Bécane
  • Fonction : Auteur
Hélène Radvanyi-Hoffman
  • Fonction : Auteur
Pauline Arnaud
  • Fonction : Auteur
Arnaud Lazarus
  • Fonction : Auteur
Anthony Béhin
  • Fonction : Auteur
Abdallah Fayssoil
  • Fonction : Auteur
Pascal Laforêt
  • Fonction : Auteur
Tanya Stojkovic
  • Fonction : Auteur
Bruno Eymard
  • Fonction : Auteur
Denis Duboc
  • Fonction : Auteur

Résumé

Background: In myotonic dystrophy type 1, the association between mutation size (CTG expansion) and the severity of cardiac involvement is controversial. Methods and Results—We selected 855 patients with myotonic dystrophy type 1 (women, 51%; median age, 37 years), with genetic testing performed at the moment of their initial cardiac evaluation, out of 1014 patients included in the Myotonic Dystrophy Type 1-Heart Registry between January 2000 and December 2015. We studied the association between CTG expansion size and other baseline characteristics and (1) cardiac involvement at baseline and (2) the incidence of death, sudden death, and other cardiac adverse events. At initial presentation, the median CTG expansion size was 530 (interquartile range, 300–830). In multivariate analysis, larger expansions were associated with the presence at baseline of conduction defects on the ECG and left ventricular systolic dysfunction. In a median 11.5 years of follow-up period, 210 patients died (25%), including 32 suddenly (4%). Supraventricular arrhythmias developed over lifetime in 166 patients (19%), sustained ventricular tachyarrhythmias in 17 (2%), and permanent pacemakers were implanted in 181 (21%). In Cox regression analyses, larger CTG expansions were significantly associated with (1) total death, sudden death, and pacemaker implantation in a model, including CTG expansion size, age, sex, diabetes mellitus, and (2) all end points except sudden death in a model including all baseline characteristics. Conclusions—The size of the CTG expansion in the blood of myotonic dystrophy type 1 patients is associated with total and sudden deaths, conduction defects, left ventricular dysfunction, and supraventricular arrhythmias. Clinical Trial Registration— URL: https://www.clinicaltrials.gov . Unique Identifier: NCT01136330

Dates et versions

hal-03830988 , version 1 (26-10-2022)

Identifiants

Citer

Caroline Chong-Nguyen, Karim Wahbi, Vincent Algalarrondo, Henri Marc Bécane, Hélène Radvanyi-Hoffman, et al.. Association Between Mutation Size and Cardiac Involvement in Myotonic Dystrophy Type 1. Circulation: Cardiovascular Genetics, 2017, 10 (3), ⟨10.1161/CIRCGENETICS.116.001526⟩. ⟨hal-03830988⟩
28 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More